WO1997009170A1 - Method and composition for the manufactue of ophthalmic lenses - Google Patents

Method and composition for the manufactue of ophthalmic lenses Download PDF

Info

Publication number
WO1997009170A1
WO1997009170A1 PCT/US1996/014098 US9614098W WO9709170A1 WO 1997009170 A1 WO1997009170 A1 WO 1997009170A1 US 9614098 W US9614098 W US 9614098W WO 9709170 A1 WO9709170 A1 WO 9709170A1
Authority
WO
WIPO (PCT)
Prior art keywords
radiation
photoinitiator
activated
initiator
wavelength range
Prior art date
Application number
PCT/US1996/014098
Other languages
French (fr)
Inventor
Ronald D. Blum
Original Assignee
Blum Ronald D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blum Ronald D filed Critical Blum Ronald D
Priority to CA002230646A priority Critical patent/CA2230646A1/en
Priority to JP51132697A priority patent/JP2001510404A/en
Priority to BR9610409-0A priority patent/BR9610409A/en
Priority to AU69635/96A priority patent/AU6963596A/en
Priority to EP96930670A priority patent/EP0847330A1/en
Priority to IL12347896A priority patent/IL123478A0/en
Publication of WO1997009170A1 publication Critical patent/WO1997009170A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00Producing optical elements, e.g. lenses or prisms
    • B29D11/00009Production of simple or compound lenses
    • B29D11/00432Auxiliary operations, e.g. machines for filling the moulds
    • B29D11/00442Curing the lens material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • B29C35/08Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation
    • B29C35/0805Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation
    • B29C2035/0833Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould by wave energy or particle radiation using electromagnetic radiation using actinic light

Definitions

  • This invention relates to improved methods by which plastic resins can be cured to form ophthalmic lenses, semifinished blanks and optical preforms .
  • Ophthalmic lenses often have complex geometries, with certain prescriptions having variations in thicknesses across the optic area of greater than an order of magnitude. Since the curing process is accompanied by shrinkage, a key objective of curing process development efforts is to be able to accommodate shrinkage without unduly increasing the cure time. I have developed a curing method for ophthalmic lenses that uses visible light to initiate cure, while nevertheless creating a colorless product.
  • the lens does not undergo a prerelease, does not develop optical aberrations caused by the formation of local heterogeneities in the resin mass due to uneven flow, and does not develop surface defects or cracks due to resin shrinkage.
  • U.S. Patent No. 4,919,850, issued to me I disclose a two stage cure process involving the use of ultraviolet polymerization initiators that allow the resin to gel under a low level of ultraviolet illumination. In this way, the initial cure rate is maintained at a low level, until the resin mass becomes a gel and mass flow ceases within the curing lens. This is important, because the risk of developing optical aberrations is highest at the initial stages of the curing process when local exotherms can induce optical aberrations through resin flow.
  • the cure rate is accelerated by increasing ultraviolet light intensity. Increasing light intensity also serves to maintain the pace of curing as the initiator becomes depleted. Alternatively, the cure rate is also accelerated in the second stage by using UV light of a shorter wavelength. A commercial version of this process has now been introduced by the Rapidcast Corporation.
  • a disadvantage of the two stage process, as disclosed in U.S. Patent No. 4,919,850 is that it typically uses two curing chambers for efficient implementation.
  • An advantage of the present invention is that a process is provided which can be efficiently implemented using a single chamber.
  • Another advantage of the invention is that the scope of the two stage curing process is expanded, rendering it applicable to resin formulations covering a wide range of chemical reactivities, functionalities, shrinkage properties, and thermal expansion characteristics.
  • a curing method for ophthalmic lenses or semi-finished lens blanks wherein a curable resin is first exposed to radiation in the wavelength range of 400-800 NM. Then, the curable resin is subjected to heat or radiation of different wavelength or intensity than that used in the first step.
  • the polymerizable resin preferably comprises: (1) a first photoinitiator that is activated by radiation in the wavelength range 400-800 NM and (2) a thermal initiator which is activated by heat, or a second photoinitiator which is activated by radiation of different wavelength or intensity than that used to activate the first photoinitiator.
  • an ophthalmic lens, semifinished blank or optical preform is provided according to any of the methods described or claimed herein.
  • a second stage of the cure process can subsequently be completed, by application of thermal energy, by application of UV light, or both.
  • the initial curing stage may take place either directly under room light, or in chambers employing visible light bulbs.
  • polymerization initiators which are activated by visible light are generally highly colored, it may appear at first sight that their use would be incompatible with the proposed application (i.e., to make an ophthalmic lens which is preferably colorless, or water white) .
  • a new class of photopolymerization initiators has been commercialized which begin as a colored species and are activated by visible light, but upon activation form colorless photodissociation products. I discovered that .such photoinitiators can be used to develop cure processes for ophthalmic lenses and semi-finished blanks.
  • a preferred photoinitiator is BAPO, available from Ciba Geigy Corp. This photopolymerization initiator is actually a mixture of two photoinitiators,
  • the phosphine oxide derivative absorbs visible light in the wavelength range 400-450 NM range, and initiates polymerization of resins incorporating acrylic, methacrylic, vinylic or allylic derivatives. Under normal room illumination, the cure rate is slow. Therefore, the mold assemblies do not require cooling or other temperature control to undergo gelation. Nevertheless, precise temperature control does produce a more uniform product and improves product consistency and yield. If temperature control mechanisms are provided, they should be employed to control the temperature at or near room temperature, i.e., at about 15°C to 35°C.
  • this photoinitiator works in the following fashion.
  • the phosphine oxide derivative is activated and undergoes photodissociation under room light, leaving the acetophenone derivative unaffected.
  • the phosphine oxide derivative undergoes bleaching on photodissociation, so that the polymerizing resin mass becomes less colored as polymerization progresses.
  • the mold assembly is placed in a chamber equipped with ultraviolet light bulbs emitting radiation in the wavelength range of 300-
  • the near ultraviolet radiation activates the acetophenone derivative, causing the curing process to become accelerated.
  • the dissociation of the phosphine oxide derivative is completed, completing the bleaching process.
  • a residual faint yellow hue can be corrected by an addition of a small amount of a bluing additive, such as TINOPAL (available from Ciba Geigy Corp.) to the resin formulation.
  • the mold assembly may be heated along a preestablished temperature profile, ultimately reaching a final temperature in the range of about 90°-150°C, to complete the cure process and to obtain a final lens product with a glass transition temperature in the range of about
  • the final product has a lower glass transition temperature (e.g., in the range of about 30°-50°C) .
  • the cure process should be completed. The extent of the cure process can be monitored, for example, by a differential scanning calorimetric analysis of the material after cure. Whether heating is necessary to complete the cure generally depends on the monomers used in the resin formulation. Thus, if monomers used in the formulation can form homopolymers which have glass transition temperatures considerably above the room temperature
  • a phosphine oxide derivative may be used which initiates cure under visible light as before.
  • a thermal polymerization initiator such as a peroxide, a peracetate, a percarbonate or an azo derivative may be used to complete the second stage (post-gel cure) by placing the mold assembly in a thermal curing oven, typically a convection oven.
  • the two stage polymerization process described above may be carried out in glass molds, in metal molds or in a combination thereof.
  • Metal molds with reflective inner surfaces may be especially useful in reflecting radiation back into the resin mass and conducting excess heat away from the resin mass. Metal molds may also be made thinner, and thus can have a lower thermal mass than glass molds.
  • glass molds with metallized surfaces may be employed for resin formulations which require a metal mold for adhesion and thus prevent prerelease during cure.
  • the two stage polymerization method can be employed to produce lenses from resin formulations covering a wide range of chemical reactivities, functionalities, shrinkage properties, and thermal expansion characteristics. Both monomers and oligomers may be employed, and polymeric or small molecular weight additives can be included to alter physical properties of the resin formulation, such as viscosity and surface energy, as well as chemical properties of the formulation, such as oxidative and photothermal or hydrolytic stability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Thermal Sciences (AREA)
  • Casting Or Compression Moulding Of Plastics Or The Like (AREA)
  • Polymerisation Methods In General (AREA)
  • Eyeglasses (AREA)
  • Polymerization Catalysts (AREA)

Abstract

A curing method for ophthalmic lenses or semi-finished lens blanks wherein a curable resin is first exposed to radiation in the wavelength range of 400-800 nm and subsequently subjected to heat or radiation of different wavelength or intensity than that used in the first step. The polymerizable resin preferably comprises: (1) a first photoinitiator that is activated by radiation in the wavelength range of 400-800 nm and (2) a thermal initiator which is activated by heat, or a second photoinitiator which is activated by radiation of different wavelength or intensity than that used to activate the first photoinitiator.

Description

METHOD AND COMPOSITION FOR THE MANUFACTURE OF OPHTHALMIC LENSES
FIELD OF THE INVENTION:
This invention relates to improved methods by which plastic resins can be cured to form ophthalmic lenses, semifinished blanks and optical preforms . Ophthalmic lenses often have complex geometries, with certain prescriptions having variations in thicknesses across the optic area of greater than an order of magnitude. Since the curing process is accompanied by shrinkage, a key objective of curing process development efforts is to be able to accommodate shrinkage without unduly increasing the cure time. I have developed a curing method for ophthalmic lenses that uses visible light to initiate cure, while nevertheless creating a colorless product.
BACKGROUND:
Curing of organic polymerizable resins to form ophthalmic lenses and semifinished blanks has traditionally involved the use of thermal polymerization initiators as described, for example, in US Patent
3,038,210, issued to Hungerford, et al., and US Patent 3,222,432, issued to Grandparret. More recently, photocuring processes have been disclosed involving the use of ultraviolet initiators, for example, US Patent 4,166,088, issued to Neefe, and US Patent Nos. 5,364,256 and 4,879,318 to Lipscomb. Photocuring processes have allowed the development of cure cycles that are considerably shorter than standard thermal curing cycles. In all cases, it is necessary to ensure that the cure profile, which determines the rate of shrinkage, allows the cure of the bulk resin to take place in a controlled fashion while the surface still retains substantial adhesion to the mold. In this way, the lens does not undergo a prerelease, does not develop optical aberrations caused by the formation of local heterogeneities in the resin mass due to uneven flow, and does not develop surface defects or cracks due to resin shrinkage. In U.S. Patent No. 4,919,850, issued to me, I disclose a two stage cure process involving the use of ultraviolet polymerization initiators that allow the resin to gel under a low level of ultraviolet illumination. In this way, the initial cure rate is maintained at a low level, until the resin mass becomes a gel and mass flow ceases within the curing lens. This is important, because the risk of developing optical aberrations is highest at the initial stages of the curing process when local exotherms can induce optical aberrations through resin flow. After the material has undergone gelation, the cure rate is accelerated by increasing ultraviolet light intensity. Increasing light intensity also serves to maintain the pace of curing as the initiator becomes depleted. Alternatively, the cure rate is also accelerated in the second stage by using UV light of a shorter wavelength. A commercial version of this process has now been introduced by the Rapidcast Corporation.
A disadvantage of the two stage process, as disclosed in U.S. Patent No. 4,919,850 is that it typically uses two curing chambers for efficient implementation.
SUMMARY OF THE INVENTION:
An advantage of the present invention is that a process is provided which can be efficiently implemented using a single chamber.
Another advantage of the invention is that the scope of the two stage curing process is expanded, rendering it applicable to resin formulations covering a wide range of chemical reactivities, functionalities, shrinkage properties, and thermal expansion characteristics.
According to an embodiment of the present invention, a curing method for ophthalmic lenses or semi-finished lens blanks is described wherein a curable resin is first exposed to radiation in the wavelength range of 400-800 NM. Then, the curable resin is subjected to heat or radiation of different wavelength or intensity than that used in the first step. The polymerizable resin preferably comprises: (1) a first photoinitiator that is activated by radiation in the wavelength range 400-800 NM and (2) a thermal initiator which is activated by heat, or a second photoinitiator which is activated by radiation of different wavelength or intensity than that used to activate the first photoinitiator.
According to another embodiment of the invention, an ophthalmic lens, semifinished blank or optical preform is provided according to any of the methods described or claimed herein.
The above and other objects, advantages and embodiments will become readily apparent to those of skill in the art upon reading the description and claims set forth below.
Unless indicated to the contrary, each reference cited herein is incorporated by reference in its entirity.
DETAILED DESCRIPTION OF THE INVENTION:
I have developed a cure process that utilizes room light in a first stage to initiate cure and reach the gel state. A second stage of the cure process can subsequently be completed, by application of thermal energy, by application of UV light, or both. The initial curing stage may take place either directly under room light, or in chambers employing visible light bulbs.
Since polymerization initiators which are activated by visible light are generally highly colored, it may appear at first sight that their use would be incompatible with the proposed application (i.e., to make an ophthalmic lens which is preferably colorless, or water white) . Recently, a new class of photopolymerization initiators has been commercialized which begin as a colored species and are activated by visible light, but upon activation form colorless photodissociation products. I discovered that .such photoinitiators can be used to develop cure processes for ophthalmic lenses and semi-finished blanks.
A preferred photoinitiator is BAPO, available from Ciba Geigy Corp. This photopolymerization initiator is actually a mixture of two photoinitiators,
Bisdimethoxybenzoyl Trimethylpentyl Phosphine Oxide (25%, by weight) and 2-Hydroxy 2-Methyl 1-Phenyl Propanone (75% by weight) . The phosphine oxide derivative absorbs visible light in the wavelength range 400-450 NM range, and initiates polymerization of resins incorporating acrylic, methacrylic, vinylic or allylic derivatives. Under normal room illumination, the cure rate is slow. Therefore, the mold assemblies do not require cooling or other temperature control to undergo gelation. Nevertheless, precise temperature control does produce a more uniform product and improves product consistency and yield. If temperature control mechanisms are provided, they should be employed to control the temperature at or near room temperature, i.e., at about 15°C to 35°C. While not wishing to be bound by any particular theory, it is believed that this photoinitiator works in the following fashion. The phosphine oxide derivative is activated and undergoes photodissociation under room light, leaving the acetophenone derivative unaffected. The phosphine oxide derivative undergoes bleaching on photodissociation, so that the polymerizing resin mass becomes less colored as polymerization progresses. Once the resin has undergone gelation, the mold assembly is placed in a chamber equipped with ultraviolet light bulbs emitting radiation in the wavelength range of 300-
380 NM. The near ultraviolet radiation activates the acetophenone derivative, causing the curing process to become accelerated. At the same time, the dissociation of the phosphine oxide derivative is completed, completing the bleaching process. A residual faint yellow hue can be corrected by an addition of a small amount of a bluing additive, such as TINOPAL (available from Ciba Geigy Corp.) to the resin formulation.
When UV photoinitiators (such as the acetophenone derivative) are used during the second stage of cure, the mold assembly may be heated along a preestablished temperature profile, ultimately reaching a final temperature in the range of about 90°-150°C, to complete the cure process and to obtain a final lens product with a glass transition temperature in the range of about
100°-175°C. if no heat is applied and the temperature maintained at or near room temperature, the final product has a lower glass transition temperature (e.g., in the range of about 30°-50°C) . In all cases, the cure process should be completed. The extent of the cure process can be monitored, for example, by a differential scanning calorimetric analysis of the material after cure. Whether heating is necessary to complete the cure generally depends on the monomers used in the resin formulation. Thus, if monomers used in the formulation can form homopolymers which have glass transition temperatures considerably above the room temperature
(15°-30°C) , then an elevated temperature is desirable to complete the cure process.
Alternatively, a phosphine oxide derivative may be used which initiates cure under visible light as before. However, a thermal polymerization initiator, such as a peroxide, a peracetate, a percarbonate or an azo derivative may be used to complete the second stage (post-gel cure) by placing the mold assembly in a thermal curing oven, typically a convection oven. The two stage polymerization process described above may be carried out in glass molds, in metal molds or in a combination thereof. Metal molds with reflective inner surfaces may be especially useful in reflecting radiation back into the resin mass and conducting excess heat away from the resin mass. Metal molds may also be made thinner, and thus can have a lower thermal mass than glass molds. Alternatively, glass molds with metallized surfaces may be employed for resin formulations which require a metal mold for adhesion and thus prevent prerelease during cure.
The two stage polymerization method can be employed to produce lenses from resin formulations covering a wide range of chemical reactivities, functionalities, shrinkage properties, and thermal expansion characteristics. Both monomers and oligomers may be employed, and polymeric or small molecular weight additives can be included to alter physical properties of the resin formulation, such as viscosity and surface energy, as well as chemical properties of the formulation, such as oxidative and photothermal or hydrolytic stability.

Claims

CLAIMSWhat is claimed is:
1. A curing method for ophthalmic lenses or semi- finished lens blanks comprising: (A) providing a mold and a polymerizable resin, said polymerizable resin comprising (1) a first photoinitiator that is activated by radiation in the wavelength range 400-800 NM and (2) an initiator selected from the group consisting of (a) a thermal initiator which is activated by heat and (b) a second photoinitiator which is activated by radiation of different wavelength or intensity than that used to activate the first photoinitiator; (B) exposing the curable resin to radiation in the wavelength range of 400-800 NM; and (C) subsequently subjecting the curable resin to a curing environment selected from (1) heat and (2) radiation of different wavelength or intensity than that used in step (B) .
2. The method of claim 1, further comprising heat treating subsequent to step (C) .
3. The method of claim 1, in which light delivered by incandescent light bulbs is used to provide said radiation in the wavelength range of 400-800 NM.
4. The method of claim 1, in which light delivered by fluorescent light bulbs is used to provide said radiation in the wavelength range of 400-800 NM.
5. The method of claim 1, in which step (B) further comprises control of temperature in the range 15°C-45°C.
6. The method of claim 1, in which said first photoinitiator is Bisdimethoxybenzoyl Trimethylpentyl Phosphine Oxide.
7. The method of claim 1, in which said second photoinitiator is selected as the initiator.
8. The method of claim 7, in which said second photoinitiator is .2-Hydroxy 2-Methyl 1-Phenyl Propane.
9. The method of claim 1, in which said thermal initiator is selected as the initiator.
10. The method of claim 11, in which said thermal initiator is selected from the group consisting of a peroxide, a peracetate, a percarbonate and an azo derivative.
PCT/US1996/014098 1995-09-01 1996-09-03 Method and composition for the manufactue of ophthalmic lenses WO1997009170A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002230646A CA2230646A1 (en) 1995-09-01 1996-09-03 Method and composition for the manufacture of ophthalmic lenses
JP51132697A JP2001510404A (en) 1995-09-01 1996-09-03 Methods and compositions for the manufacture of spectacle lenses
BR9610409-0A BR9610409A (en) 1995-09-01 1996-09-03 Method and composition for the manufacture of ophthalmic lenses
AU69635/96A AU6963596A (en) 1995-09-01 1996-09-03 Method and composition for the manufactue of ophthalmic lenses
EP96930670A EP0847330A1 (en) 1995-09-01 1996-09-03 Method and composition for the manufactue of ophthalmic lenses
IL12347896A IL123478A0 (en) 1995-09-01 1996-09-03 Method and composition for the manufacture of ophthalmic lenses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52281595A 1995-09-01 1995-09-01
US08/522,815 1995-09-01

Publications (1)

Publication Number Publication Date
WO1997009170A1 true WO1997009170A1 (en) 1997-03-13

Family

ID=24082484

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/014098 WO1997009170A1 (en) 1995-09-01 1996-09-03 Method and composition for the manufactue of ophthalmic lenses

Country Status (10)

Country Link
EP (1) EP0847330A1 (en)
JP (1) JP2001510404A (en)
KR (1) KR19990044298A (en)
CN (1) CN1200696A (en)
AU (1) AU6963596A (en)
BR (1) BR9610409A (en)
CA (1) CA2230646A1 (en)
IL (1) IL123478A0 (en)
MX (1) MX9801691A (en)
WO (1) WO1997009170A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056527A1 (en) * 1999-03-19 2000-09-28 Optical Dynamics Corporation Plastic lens systems, compositions, and methods
AU739975B2 (en) * 1998-04-15 2001-10-25 Alcon Laboratories, Inc. High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
US6313187B2 (en) 1998-04-15 2001-11-06 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
US6630083B1 (en) 1999-12-21 2003-10-07 Johnson & Johnson Vision Care, Inc. Methods and compositions for the manufacture of ophthalmic lenses

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4878796B2 (en) * 2004-09-06 2012-02-15 富士フイルム株式会社 Manufacturing method of optical film
US7838570B2 (en) * 2005-01-14 2010-11-23 Xerox Corporation Radiation curable inks

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919850A (en) * 1988-05-06 1990-04-24 Blum Ronald D Method for curing plastic lenses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919850A (en) * 1988-05-06 1990-04-24 Blum Ronald D Method for curing plastic lenses

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739975B2 (en) * 1998-04-15 2001-10-25 Alcon Laboratories, Inc. High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
US6313187B2 (en) 1998-04-15 2001-11-06 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
WO2000056527A1 (en) * 1999-03-19 2000-09-28 Optical Dynamics Corporation Plastic lens systems, compositions, and methods
US6630083B1 (en) 1999-12-21 2003-10-07 Johnson & Johnson Vision Care, Inc. Methods and compositions for the manufacture of ophthalmic lenses

Also Published As

Publication number Publication date
AU6963596A (en) 1997-03-27
EP0847330A1 (en) 1998-06-17
IL123478A0 (en) 1998-09-24
CA2230646A1 (en) 1997-03-13
BR9610409A (en) 1999-12-21
MX9801691A (en) 1998-11-29
JP2001510404A (en) 2001-07-31
CN1200696A (en) 1998-12-02
KR19990044298A (en) 1999-06-25

Similar Documents

Publication Publication Date Title
US5470892A (en) Polymerizable resin for forming clear, hard plastics
US5989462A (en) Method and composition for producing ultraviolent blocking lenses
US4879318A (en) Plastic lens composition and method for the production thereof
EP0640469B1 (en) Method for producing optical lenses
EP0404888B1 (en) Plastic lens compositions and apparatus for the production thereof
US6926510B2 (en) Plastic lens systems and compositions
US5807906A (en) Process for obtaining a transparent article with a refractive index gradient
JP2505779B2 (en) Method for manufacturing photochromic articles
CA2395229C (en) Methods and compositions for the manufacture of ophthalmic lenses
EP0847330A1 (en) Method and composition for the manufactue of ophthalmic lenses
AU2001221025B2 (en) Compositions and methods for the manufacture of ophthalmic lenses
WO2004020183A1 (en) Methods for preparing composite photochromic ophthalmic lenses
AU2004201927B2 (en) Plastic lens compositions
WO1997017182A1 (en) Method for producing an optical article using visible light radiation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96197964.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AU BB BG BR CA CN CZ EE GE HU IL IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK TR TT UA UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2230646

Country of ref document: CA

Ref document number: 2230646

Country of ref document: CA

Kind code of ref document: A

Ref document number: 1997 511326

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1019980701535

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/001691

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1996930670

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996930670

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019980701535

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1996930670

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019980701535

Country of ref document: KR